Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Korea Small Cap Gem Insights - Relative Outperformance Vs KOSDAQ

An Early Look at the Potential KOSDAQ150 Rebalance Candidates in December 2026

Douglas Research Advisory

Equity Bottom-Up

<ul>
<li>Seers (458870 KS) is a digital healthcare firm in Korea that specializes in wearable medical biosensors, artificial intelligence (AI)-driven clinical data analysis, and remote patient monitoring (RPM) platforms.</li>
<li>Given the company's surging sales and profit growth, I believe it deserves to trade at 20x P/E. </li>
<li>Assuming consensus net profit estimate of 86.8 billion won, a 20X P/E suggests market cap of 1.7 trillion won, representing 110% upside from current levels (about 44,000 won per share). </li>
</ul>


Seers (458870 KS) is a digital healthcare firm in Korea that specializes in wearable medical biosensors, artificial intelligence (AI)-driven clinical data analysis, and remote patient monitoring (RPM) platforms.
Given the company's surging sales and profit growth, I believe it deserves to trade at 20x P/E. 
Assuming consensus net profit estimate of 86.8 billion won, a 20X P/E suggests market cap of 1.7 trillion won, representing 110% upside from current levels (about 44,000 won per share). 


Seers

Korea Small Cap Gem #68: Seers Co